| Product Information |
DR-XY48002_PI_01.pdf
|
| Registration Number |
DR-XY48002
|
| Generic Name |
Dolutegravir (as sodium) + Lamivudine + Tenofovir
disoproxil fumarate
|
| Brand Name |
None
|
| Dosage Strength |
50 mg/ 300 mg/ 300 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antiviral Combination
|
| Packaging |
100 cc opaque white HDPE container (with a 38 mm neck and child-resistant plastic cap with pulp liner) x 30's (box of 30's)
|
| Manufacturer |
Hetero Labs Limited
|
| Country of Origin |
India
|
| Trader |
N/A
|
| Importer |
Camber Pharmaceuticals, Inc.
|
| Distributor |
Camber Pharmaceuticals, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
05 May 2022
|
| Expiry Date |
05 May 2025
|